Frontline Tafasitamab Combo Improves PFS in Newly Diagnosed DLBCL

Intravenous Olvi-Vec Yields Responses in NSCLC and SCLC Following Progression

Videos

Re-Engaging Patients in Medical Oncology With Scientific Discourse Watch Now

Understanding the AQUILA Study Design in High-Risk Smoldering Multiple Myeloma   Watch Now

Trending

Recurrence Rates Higher With Axillary Lymph Node Biopsy After NAT Chemo   Read More

Subcutaneous Isatuximab Regimens Show Efficacy in R/R Multiple Myeloma   Read More